3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Thoracic
1
Sarcoma
1
Genitourinary
1
Breast
1
Conditions
Stomach Neoplasms
1
Pancreatic Neoplasms
1
Gastrointestinal Stromal Tumors
1
Gallbladder Neoplasms
1
Esophageal Neoplasms
1
Duodenal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Hepatocellular
1
Biliary Tract Neoplasms
1
Interventions
pembrolizumab
5
Specimen Handling
5
Nivolumab
5
Cyclophosphamide
5
Magnetic Resonance Spectroscopy
4
Bevacizumab
4
Oxaliplatin
3
Leucovorin
3
Cisplatin
3
sargramostim
2
fludarabine
2
cabozantinib
2
aflibercept
2
X-Rays
2
Stem Cell Transplantation
2
Sirolimus
2
Paclitaxel
2
Mesna
2
Melphalan
2
Irinotecan
2
Ipilimumab
2
Ifosfamide
2
Fluorouracil
2
Fluorodeoxyglucose F18
2
Filgrastim
2
Etoposide
2
Erlotinib Hydrochloride
2
Doxorubicin
2
Cryosurgery
2
Busulfan
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
Rivaroxaban
×
Sarcoma
×
Clear all
NCT03139487
2020-01-06
PRIORITY
Asan Medical Center
Phase 2
Unknown
176 enrolled